Literature DB >> 19633773

Pipobroman gets regulatory approval outside Germany.

Antonis G Tsamaloukas.   

Abstract

Year:  2008        PMID： 19633773      PMCID： PMC2696734          DOI： 10.3238/arztebl.2008.0071d

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  3 in total

1.  Long-term follow-up of young patients with essential thrombocythemia treated with pipobroman.

Authors:  Francesco Passamonti; Elisa Rumi; Lucia Malabarba; Luca Arcaini; Ester Orlandi; Ercole Brusamolino; Cristiana Pascutto; Mario Cazzola; Mario Lazzarino
Journal:  Ann Hematol       Date:  2004-06-03       Impact factor: 3.673

2.  A large proportion of patients with a diagnosis of essential thrombocythemia do not have a clonal disorder and may be at lower risk of thrombotic complications.

Authors:  C N Harrison; R E Gale; S J Machin; D C Linch
Journal:  Blood       Date:  1999-01-15       Impact factor: 22.113

3.  Mpl Baltimore: a thrombopoietin receptor polymorphism associated with thrombocytosis.

Authors:  Alison R Moliterno; Donna M Williams; Laura I Gutierrez-Alamillo; Roberto Salvatori; Roxann G Ingersoll; Jerry L Spivak
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-21       Impact factor: 11.205
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.